Paysign Inc

Paysign Inc(PAYS)股票分析

$14.800

-0.759 (-5.13%)收盤時

Loading chart…
最高
15.800
開盤
15.700
成交量加權均價
14.97
成交量
1.23M
市值
212.44M
最低
14.300
成交金額
18.35M
企業價值/稅息折舊攤銷前利潤(TTM)
17.66

Paysign, Inc. is a provider of prepaid card programs, patient affordability offerings, digital banking services and integrated payment processing designed for businesses, consumers and government institutions. The Company’s payment solutions are utilized by its corporate customers to increase customer loyalty, increase patient adherence rates, reduce administration costs and streamline operations. It markets its prepaid card solutions under its Paysign brand. Its end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. It operates on a payments platform with fintech capabilities that can be seamlessly integrated with its clients’ systems. It offers donor engagement app, which integrates seamlessly with existing donor management systems, delivering immediate value to plasma centers.

AI 分析 of Paysign Inc (PAYS)

買進

Paysign Inc is a good buy right now due to its strong recent performance, with a current price of $15.37 and a year-to-date change of +209.88%. The company reported a Q2 EPS of $0.11, exceeding expectations by $0.05, and raised its full-year revenue guidance to between $114 million and $117 million, showcasing robust growth potential. However, the main risk is the high forward P/E ratio of 29.59, which suggests that the stock may be overvalued if growth slows.

估值指標

Paysign Inc(PAYS)目前預期本益比為 29.59,5 年平均預期本益比為 55.91。

預期本益比

合理
5 年均值 P/E
55.91
目前P/E
29.59
高估
201.65
低估
-89.82

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
17.19
目前EV/EBITDA
17.66
高估
22.37
低估
12.02

預期股價營收比

嚴重高估
5 年均值 P/S
3.08
目前P/S
6.40
高估
4.02
低估
2.14

Alphio AI 對 PAYS 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%PAYS

$5.83

情境價格

基

基準

基準 · 50%PAYS

$5.22

情境價格

悲

悲觀

悲觀 · 25%PAYS

$3.85

情境價格

持有 PAYS 的大戶

P

Punch & Associates Investment Management, Inc.

+ 持有PAYS

-5.54%

3個月報酬率

事件時間軸

2026-08-05 (ET)

17:00:00

Paysign Reports Q2 Revenue of $28.25M

17:00:00

Sees Q3 Revenue of $28.5M-$30M

17:00:00

Raises FY26 Revenue Outlook to $114M-$117M

2026-05-13 (ET)

10:40:00

Sees Q2 Revenue of $26.2M-$26.7M

10:40:00

Paysign Sees 2026 Revenue Guidance of $106.5M-$110.5M

資訊

PAYS 常見問題 —— 由 Alphio AI 解答

Paysign, Inc. is a provider of prepaid card programs, patient affordability offerings, digital banking services and integrated payment processing designed for businesses, consumers and government institutions. The Company’s payment solutions are utilized by its corporate customers to increase customer loyalty, increase patient adherence rates, reduce administration costs and streamline operations. It markets its prepaid card solutions under its Paysign brand. Its end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. It operates on a payments platform with fintech capabilities that can be seamlessly integrated with its clients’ systems. It offers donor engagement app, which integrates seamlessly with existing donor management systems, delivering immediate value to plasma centers. It operates in the Industrials sector (SERVICES-BUSINESS SERVICES, NEC industry).

Paysign Inc is a good buy right now due to its strong recent performance, with a current price of $15.37 and a year-to-date change of +209.88%. The company reported a Q2 EPS of $0.11, exceeding expectations by $0.05, and raised its full-year revenue guidance to between $114 million and $117 million, showcasing robust growth potential. However, the main risk is the high forward P/E ratio of 29.59, which suggests that the stock may be overvalued if growth slows.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易